Matsun Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Matsun Exports Pharmaceutical Export Portfolio Dataset — 4 Products, $148.6K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Matsun Exports — Pharmaceutical Exporter Profile (2026) | 4 Products, $148.6K Trade | TransData Nexus

Product Portfolio — Top 4 by Export Value

Matsun Exports exports 4 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Osimertinib	Advanced Oncology	$57.1K	14	5.2%	4
2	Olaparib	Advanced Oncology	$39.2K	10	4.3%	6
3	Cetuximab	Advanced Oncology	$38.8K	10	4.6%	3
4	Ustekinumab	Biologics & Immunotherapy	$13.5K	4	1.1%	13

Matsun Exports exports 4 pharmaceutical products across 2 therapeutic categories with a total export value of $148.6K. The top category is Advanced Oncology (90.9% of portfolio), followed by Biologics & Immunotherapy (9.1%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Matsun Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Matsun Exports is a Mumbai-based pharmaceutical exporter established on December 1, 2021. The company is led by Mr. Rahul Saroj, an entrepreneur with over a decade of experience in the pharmaceutical industry. Matsun Exports specializes in exporting finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, across various therapeutic categories. The company's registered office is located at Shop No.17, Madhuvihar CHSL, M.G. Road No.04, Behind Patel Nagar, Kandivali West, Mumbai-400067, Maharashtra, India.

2Manufacturing Facilities

Matsun Exports operates in compliance with Good Manufacturing Practices (GMP) and holds ISO 9001:2015 certification, ensuring adherence to international quality standards. While specific details about the company's manufacturing facilities are not publicly disclosed, Matsun Exports offers third-party manufacturing services, collaborating with GMP-compliant and ISO-certified production facilities to meet clients' unique requirements.

3Key Leadership

Mr. Rahul Saroj serves as the Managing Director of Matsun Exports, bringing over 10 years of industry expertise and international export-import training to the company. Specific information regarding other key executives, such as the Chief Financial Officer, is not publicly available.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Matsun Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Matsun Exports has demonstrated a significant presence in regulated markets, exporting finished pharmaceutical formulations to various countries. Notably, the company has exported Osimertinib and Olaparib to Brazil, as evidenced by export data from November 2025. (eximpedia.app) While specific regulatory approvals in the United States, European Union, United Kingdom, Australia, and Japan are not publicly disclosed, the company's adherence to GMP and ISO certifications suggests compliance with international standards, facilitating market access in these regions.

2Emerging Markets

Matsun Exports has expanded its reach to emerging markets, including Africa, Latin America, and Southeast Asia. The company's diverse product portfolio, encompassing oncology, HIV, nephrology, virology, and critical care medications, positions it to meet the healthcare needs of these regions. While specific details about WHO prequalification are not available, the company's commitment to quality and ethical practices enhances its potential for market penetration in these areas.

3Geographic Strategy

Matsun Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Matsun Exports' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's adherence to GMP and ISO 9001:2015 certifications suggests a commitment to quality standards that align with FDA expectations, potentially facilitating market access in the United States.

2WHO & EU GMP

Matsun Exports' GMP compliance and ISO 9001:2015 certification indicate adherence to international quality standards. While specific details about WHO prequalification and EU GMP certificates are not publicly disclosed, the company's commitment to quality and ethical practices enhances its potential for market acceptance in these regions.

3CDSCO & Indian Regulatory

Matsun Exports holds a Udyam/Msme registration number (UDYAM-MH-18-0117557), indicating its recognition as a micro-enterprise under the Ministry of Micro, Small, and Medium Enterprises (MSME) in India. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not publicly available.

Matsun Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Matsun Exports operates in a competitive landscape with numerous pharmaceutical exporters globally. While specific market share comparisons are not publicly available, the company's focus on high-quality, affordable pharmaceutical products positions it favorably in the market. Its specialization in oncology, HIV, nephrology, virology, and critical care medications differentiates it from competitors, catering to diverse therapeutic needs.

2Key Differentiators

Matsun Exports' key differentiators include its extensive product portfolio, competitive pricing, reliable delivery through efficient logistics and cold chain management, and a commitment to quality assurance with GMP and ISO 9001:2015 certifications. These strengths contribute to its competitive advantage in the pharmaceutical export market.

3Strategic Position

Matsun Exports' strategic direction focuses on exporting finished pharmaceutical formulations across various therapeutic categories, including oncology, HIV, nephrology, virology, and critical care. The company's commitment to quality, affordability, and ethical practices positions it as a reliable partner for healthcare providers and pharmacies worldwide. Future outlooks suggest continued expansion into emerging markets and strengthening of its global presence.

Buyer Due Diligence Brief — Evaluating Matsun Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Matsun Exports has demonstrated a consistent track record in exporting pharmaceutical products, with a total export value of $149K USD across 38 shipments, as per TransData Nexus proprietary trade data from 2022 to 2026. The company's portfolio concentration, with top 5 products accounting for 100% of exports, indicates a focused approach. Reliability indicators include adherence to GMP and ISO 9001:2015 certifications, ensuring product quality and consistency.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and compliance:

FDA Registration: Confirm the manufacturer's registration with the U.S. Food and Drug Administration.

WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.

EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Matsun Exports

How many pharmaceutical products does Matsun Exports export from India?

Matsun Exports exports 4 pharmaceutical products across 2 therapeutic categories. The top exports are Osimertinib ($57.1K), Olaparib ($39.2K), Cetuximab ($38.8K), Ustekinumab ($13.5K). Total export value is $148.6K.

What is Matsun Exports's total pharmaceutical export value?

Matsun Exports's total pharmaceutical export value is $148.6K, based on 38 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Matsun Exports cover?

Matsun Exports exports across 2 therapeutic categories. The largest are Advanced Oncology (90.9%, 3 products), Biologics & Immunotherapy (9.1%, 1 products).

Get Full Matsun Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Matsun Exports

Matsun Exports — Export Portfolio & Destination Treemap

Who is Matsun Exports? — Company Overview & Market Position

What Does Matsun Exports Export? — Product Portfolio Analysis

Top Products by Export Value

Matsun Exports Therapeutic Categories — 2 Specializations